No Detectable Alterations in Immunogenicity following Terminal Severe Dry-Heat Treatment of High-Purity Factor VIII (Liberate) and Factor IX (HP9) Concentrates-Reference-Cited by-同舟云学术

No Detectable Alterations in Immunogenicity following Terminal Severe Dry-Heat Treatment of High-Purity Factor VIII (Liberate) and Factor IX (HP9) Concentrates

Published:1995-11 Issue:4 Volume:69 Page:319-327
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:

Author:

MacGregor I. R.,McLaughlin L. E.,MacGregor M. C.,Prowse C. V.,Pepper D. S.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.1995.tb00367.x/fullpdf

Reference17 articles.

1. Monoclonal antibodies directed against human alpha-thrombin and the thrombin-antithrombin III complex;Dawes;Thromb Res,1984

2. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation;Cleland;Crit Rev Ther Drug Carrier Syst,1993

3. Safety and tolerance of recombinant interferon alpha-2a (Roferon-A) in cancer patients;Jones;Cancer,1986

4. Assessment of the antigenic response in humans to recombinant mutant interferon beta;Konrad;J Clin Immunol,1987

5. Inhibitors in Hemophilia A: Are some products safer;Briet;Semin Hematol,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of rabbit polyclonal antibodies to assess neoantigenicity following viral reduction of an alpha-1-proteinase inhibitor preparation;Biologicals;2006-09

2. Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism;Journal of Biological Chemistry;1999-12

3. Use of high-resolution techniques for the characterization of clotting factor VIII;Journal of Chromatography A;1999-08

4. Neoantigens and antibodies to factor VIII;Blood Reviews;1998-06

5. Heating Lyophilised Factor VIII Does Not Alter Its Recognition by Specific Antibodies;Vox Sanguinis;1997-07